P-glycoprotein-mediated transport of moxifloxacin in a calu-3 lung epithelial cell model

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 4, 2009, Pages 1457-1462

  Brillault, Julien ^a,b   De Castro, Whocely Victor ^a,b   Harnois, Thomas ^c   Kitzis, Alain ^b,c,d   Olivier, Jean Christophe ^a,b   Couet, William ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MOXIFLOXACIN; PROBENECID; RIFAMPICIN;

ACTIVE TRANSPORT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG TRANSPORT; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; LUNG; P-GLYCOPROTEIN; QUINOLINES; RIFAMPIN;

EID: 65649129716     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01253-08     Document Type: Article

References (31)

1. Ahmed, S., N. T. Vo, T. Thalhammer, F. Thalhammer, K. B. Gattringer, and W. Jager. 2008. Involvement of M.rp2 (Abcc2) in biliary excretion of moxi-floxacin and its metabolites in the isolated perfused rat liver. J. Pharm. Pharmacol. 60:55-62.
2. Alvarez, A. I., M. Perez, J. G. Prieto, A. J. Molina, R. Real, and G. Merino. 2008. Fluoroquinolone efflux mediated by ABC transporters. J. Pharm. Sci. 97:3483-3493.
3. Ballow, C, J. Lettieri, V. Agarwal, P. Liu, H. Stass, and J. T. Sullivan. 1999. Absolute bioavailability of moxifloxacin. Clin. Ther. 21:513-522. (Pubitemid 29198039)
4. Bentz, J., T. T. Tran, J. W. Polli, A. Ayrton, and H. Ellens. 2005. The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km. Pharm. Res. 22:1667-1677. (Pubitemid 41355906)
5. Binaschi, M., R. Supino, R. A. Gambetta, G. Giaccone, E. Prosperi, G. Capranico, I. Cataldo, and F. Zunino. 1995. MRF gene overexpression in a human doxorubicin-resistant SCLC cell line: alterations in cellular pharma-cokinetics and in pattern of cross-resistance. Int. J. Cancer 62:84-89.
6. Brayton, J. J., Q. Yang, R. J. Nakkula, and J. D. Walters. 2002. An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells. J. Periodontol. 73:1267-1272. (Pubitemid 35469673)
7. Collett, A., J. Tanianis-Hughes, and G. Warhurst. 2004. Rapid induction of F-glycoprotein expression by high permeability compounds in colonic cells in vitro: a possible source of transporter mediated drag interactions? Biochem. Pharmacol. 68:783-790. (Pubitemid 38953460)
8. Endter, S., U. Becker, N. Daum, H. Huwer, C. M. Lehr, M. Gumbleton, and C. Ehrhardt. 2007. P-glycoprotein (MDRl) functional activity in human alveolar epithelial cell monolayers. Cell Tissue Res. 328:77-84. (Pubitemid 46411916)
9. Forbes, B., and C. Ehrhardt. 2005. Human respiratory epithelial cell culture for drug delivery applications. Eur. J. Pharm. Biopharm. 60:193-205. (Pubitemid 40804561)
10. Geys, J., L. Coenegrachts, J. Vercammen, Y. Engelborghs, A. Nemmar, B. Nemery, and P. H. Hoet. 2006. In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol. Lett. 160:218-226. (Pubitemid 41628109)
11. Hamilton, K. O., G. Backstrom, M. A. Yazdanian, and K. L. Audus. 2001. F-glycoprotein efflux pump expression and activity in Calu-3 cells. J. Pharm. Sci. 90:647-658. (Pubitemid 32378386)
12. Hamilton, K. O., E. Topp, I. Makagiansar, T. Siahaan, M. Yazdanian, and K. L. Audus. 2001. Multidrug resistance-associated protein-1 functional ac-tivity in Calu-3 cells. J. Pharmacol. Exp. Ther. 298:1199-1205. (Pubitemid 32761940)
13. Langlois, M.-H., M. Montagut, J.-P. Dubost, J. Grellet, and M.-C. Saux. 2005. Frotonation equilibrium and lipophilics of moxifloxacin. J. Pharm. Biomed. Anal. 37:389-393.
14. Lehmann, T., C. Kohler, E. Weidauer, C. Taege, and H. Foth. 2001. Expression of MRPl and related transporters in human lung cells in culture. Toxicology 167:59-72. (Pubitemid 32830947)
15. Magnarin, M., M. Morelli, A. Rosati, F. Bartoli, L. Candussio, T. Giraldi, and G. Decorti. 2004. Induction of proteins involved in multidrug resistance (P-glycoprotein, MRPl, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PKl cells. Eur. J. Pharmacol. 483:19-28. (Pubitemid 38056600)
16. Marchand, S., M. Chenel, I. Lamarche, C. Pariât, and W. Couet. 2003. Dose ranging pharmacokinetics and brain distribution of norfloxacin using micro-dialysis in rats. J. Pharm. Sei. 92:2458-2465. (Pubitemid 37484772)
17. Marchand, S., D. Frasca, C. Dahyot-Fizelier, C. Breheret, O. Mimoz, and W. Couet. 2008. Lung microdialysis study of levofloxacin in rats following intra-venous infusion at steady state. Antimicrob. Agents Chemother. 52:3074-3077.
18. Marier, J. F., J. L. Deschenes, A. Hage, E. Seliniotakis, A. Gritsas, T. Flarakos, F. Beaudry, and P. Vachon. 2005. Enhancing the uptake of dex-tromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil. Life Sci. 77:2911-2926. (Pubitemid 41390955)
19. Michot, J. M., C. Serai, F. Van Bambeke, M. P. Mingeot-Leclercq, and P. M. Tulkens. 2005. Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxi-floxacin) in J774 macrophages. Antimicrob. Agents Chemother. 49:2429-2437. (Pubitemid 40734476)
20. Mills, J. B., K, A. Rose, N. Sadagopan, J. Sahi, and S. M. de Morais. 2004. Induction of drug metabolism enzymes and MDRl using a novel human hepatocyte cell line. J. Pharmacol. Exp. Ther. 309:303-309. (Pubitemid 38393143)
21. Miravitlles, M., and A. Anzueto. 2008. Moxifloxacin: a respiratory fluoro-quinolone. Expert Opin. Pharmacother. 9:1755-1772.
22. Mukherjee, J. S., M. L. Rich, A. R. Socci, J. K. Joseph, F. A. Viru, S. S. Shin, J. J. Furin, M. C. Becerra, D. J. Barry, J. Y. Kim, J. Bayona, P. Farmer, M. C. Smith Fawzi, and K. J. Seung. 2004. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet 363:474-481. (Pubitemid 38210067)
23. Nljland, H. M., R. Ruslami, A. J. Suroto, D. M. Burger, B. Alisjahbana, R. van Crevel, and R. E. Aarnoutse. 2007. Rifampicin reduces plasma concen-trations of moxifloxacin in patients with tuberculosis. Clin. Infect. Dis. 45: 1001-1007. (Pubitemid 47580349)
24. Oliphant, C. M., and G. M. Green. 2002. Quinolones: a comprehensive review. Am. Fam. Physician 65:455-464. (Pubitemid 34174022)
25. Schentag, J. J. 2000. Clinical pharmacology of the fluoroquinolones: studies in human dynamic/kinetic models. Clin. Infect. Dis. 31(Suppl. 2):S40-S44. (Pubitemid 32269608)
26. Scninkel, A. H., and J. W. Jonker. 2003. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev 55:3-29 (Pubitemid 36078452)
27. Shen, B. Q., W. E. Finkbeiner, J. J. Wine, R. J. Mrsny, and J. H. Widdi-combe. 1994. Calu-3: a human airway epithelial cell line that shows cAMF-dependent Cl-secretion. Am. J. Physiol. 266:L493-L501. (Pubitemid 2104386)
28. Soman, A., D. Honeybourne, J. Andrews, G. Jevons, and R. Wise. 1999. Concentrations of moxifloxacin in serum and pulmonary compartments fol-lowing a single 400 mg oral dose in patients undergoing fibre-optic bron-choscopy. J. Antimicrob. Chemother. 44:835-838.
29. Van Bambeke, F., J. M. Michot, J. Van Eldere, and P. M. Tulkens. 2005. Quinolones in 2005: an update. Clin. Microbiol. Infect. 11:256-280. (Pubitemid 40443832)
30. Weiner, M., W. Burman, C. C. Luo, C. A. Peloquin, M. Engle, S. Goldberg, V. Agarwal, and A. Vernon. 2007. Effects of rifampin and multidrug resis-tance gene polymorphism on concentrations of moxifloxacin. Antimicrob. Agents Chemother. 51:2861-2866. (Pubitemid 47206223)
31. Wise, R., J. M. Andrews, G. Marshall, and G. Hartman. 1999. Pharmacoki-netics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration. Antimicrob. Agents Chemother. 43:1508-1510. (Pubitemid 29259357)